Your selected option
2g
—
per unit at the selected option
Calculating live option comparison…Code Copied
/
The current listing references a laboratory report for submitted sample DD00126B(15).
The report describes the submitted sample and does not by itself establish every size, packaged unit, or future lot.
Lab sample: SD260715-011 (142956) (DD00126B(15))
Reported: July 20, 2026
Mitragynine: 87.01% (870.12 mg/g)
Available to adults where permitted by law. Orders are subject to the destination rules shown in our shipping information. Contact support@kratomparadise.com with order, bulk, or availability questions.
MIT 90% Mitragynine Extract Powder is unflavored dry mitragynine extract powder sold by net weight. Select 2g, 5g, 10g, or 25g.
Unflavored MIT 90% mitragynine extract powder in 2g, 5g, 10g, and 25g packages. Current price and availability appear in the selector above.
Read 90% MIT Extract Powder: Product Label vs Current COA Result before comparing the label with the submitted-sample result.
The current listing references PharmLabs San Diego sample DD00126B(15), sample ID SD260715-011 (142956), reported July 20, 2026. The concentrate report lists 87.01% mitragynine (870.12 mg/g) and 9.08% speciociliatine (90.79 mg/g).
7-hydroxymitragynine and MGM-15 are reported as not detected for the submitted sample. The stated LOQ is 0.025 ppm for 7-hydroxymitragynine and 0.562 ppm for MGM-15. Open the complete powder COA PDF.
90% is the current product-line label. The laboratory result is a separate measured value for the identified submitted sample. The report does not establish every size, packaged unit, or future lot as the same tested sample.
This product is loose, unflavored extract powder rather than a tablet, gummy, or liquid. Keep the original pouch closed, dry, and labeled, and do not combine different product lines, sizes, or lots in one container.
This is a mitragynine product. It is not Oxonol, MGM-15, or a 7-OH product. Mitragynine is psychoactive, and this listing does not provide dosing, conversion, medical, or legal advice. For adults where permitted by law.
Live value comparison
Prices and per-unit comparisons come directly from the selectable variants above. Change the option and the selected cost and savings update automatically.
Your selected option
2g
—
per unit at the selected option
Calculating live option comparison…Per-unit comparisons use the smallest standard option in this product line as the baseline.
| Option | Live price | Per-unit cost | Compared with baseline |
|---|
CHOOSE WITH CLARITY
Three clear choices define the final product.
This listing follows submitted sample DD00126B(15) and sample ID SD260715-011 (142956).
This 90% MIT extract powder is unflavored. There is no flavor selector; choose only the package size.
Select from 2g, 5g, 10g, and 25g. The current listing keeps the submitted-sample report reference visible; that reference does not mean every size was separately tested.
COA DD00126B(15)
The laboratory certificate identifies the submitted sample as DD00126B(15). Its analytical table reports mitragynine at 87.01% (870.12 mg/g) for sample SD260715-011 (142956). Speciociliatine was reported at 9.08% (90.79 mg/g).
The sample was received July 15, 2026, analyzed July 17, 2026, and reported July 20, 2026. 7-hydroxymitragynine appears as ND on the certificate. ND means the analyte was not detected at the laboratory's stated reporting threshold.
Scope: the report describes that submitted sample. It does not by itself establish the composition of every size, packaged unit, or future lot.
PRODUCT IDENTITY
This listing is for mitragynine (MIT) extract powder. It is not Oxonol, MGM-15, 7-OH, or an effect-equivalent substitute. The cited Oxonol manufacturer description identifies a separate MGM-15-plus-mitragynine formula. DEA's August 26, 2026 temporary order placed MGM-15, MGM-16, and mitragynine pseudoindoxyl in Schedule I; it did not place mitragynine itself in Schedule I. Check the federal status tracker for the separate 7-OH threshold process and official records.
MIT is a distinct, naturally occurring kratom alkaloid. Keep the percentage, net weight, sample identity, and report scope attached to this product when comparing it with branded tablets, gummies, shots, or other extracts.
PACKAGE CARE AND IDENTIFICATION
Keep the product, original label, and current submitted-sample report reference connected.
Read the complete current label and keep it with the pouch. The product line, unflavored format, size, and document reference should stay together.
Close the original pouch fully after handling. Keep the outside label readable and protect the package from moisture and direct sunlight.
Do not combine different product lines, sizes, or lots in one container. Retain the original package and its current document link.
RELATED BULK PRODUCT LINE
The current bulk MIT 90% mitragynine listing also references submitted sample DD00126B(15) and offers sizes from 50g through 1kg. That shared link does not establish that every size, packaged unit, or future lot was independently tested under the report.
MIT EXTRACT QUESTIONS
Answers about the submitted-sample report, product identity, unflavored format, sizes, package care, and storage.
90% is the current product-line label. The COA separately identifies submitted sample DD00126B(15) and reports 87.01% mitragynine (870.12 mg/g) for that sample.
PharmLabs San Diego reported mitragynine at 87.01% (870.12 mg/g) for sample SD260715-011 (142956). Speciociliatine was reported at 9.08% (90.79 mg/g). The report date is July 20, 2026.
This listing is for mitragynine extract powder. On the referenced certificate, 7-hydroxymitragynine is marked ND, meaning not detected at the laboratory's stated reporting threshold.
No. This MIT 90% extract powder is unflavored and has no added flavor option. Choose only the package size.
The selector includes 2g, 5g, 10g, and 25g.
The COA identifies sample DD00126B(15), sample ID SD260715-011, and accession 142956. These identifiers keep the submitted sample separate from the retail product-line name.
Keep the original pouch fully closed in a cool, dry place with its label readable. Do not combine different product lines, sizes, or lots in one container.
CONTINUE THROUGH THE MIT COLLECTION
Explore the alternate extract certificate, matching size range, and MIT tablet formats.